Journal of Dietary Supplements

期刊简介：The Journal of Dietary Supplements (JDS) publishes original research studies relevant to dietary supplements, as defined per the U.S. Dietary Supplement Health and Education Act (DSHEA) of 1994 [108 Stat. 4325]. DSHEA defines the term "dietary supplement" as a product (other than tobacco) intended to supplement the diet that bears or contains one or more of the following dietary ingredients: a vitamin, a mineral, an herb or other botanical, an amino acid, a dietary substance for use by humans to supplement the diet by increasing total dietary intake, or a concentrate, metabolite, constituent, extract, or combination of the aforementioned ingredients. A dietary supplement is intended for ingestion in the form of a tablet, capsule, soft-gel, powder, or liquid and NOT in the form of a conventional food (studies of individual foods or dietary patterns will be rejected). The Journal publishes the following types of manuscripts: Original research articles Perspectives Scoping, systematic, and umbrella reviews Narrative reviews Reports from authoritative scientific groups or government agencies Guidelines and consensus statements Letters to the editor Letters to the Editor that refer to a recent Journal of Dietary Supplements original research article must be received within 12 weeks of the article's online publication. All letters will be subjected to editorial review and decision before acceptance. The Journal of Dietary Supplements does not accept letters that are unrelated to a specific, recently published original research article; that contain extensive unpublished data; or that engage in personal slander or invective. The Journal of Dietary Supplements does not print letters to the editor based on opinion pieces such as editorials, perspectives, commentaries, and the like, since these are clearly the opinions of the authors. Letters should be submitted by e-mail to taylor.wallace@me.com Letters must be provided as a Word document. They must be double-spaced, include line numbers, should include a title page, should have no more than 10 references, and should not exceed 1000 words . All letters to the Editor must include a conflict of interest statement. The following Journal sections apply: Nutrition, health and disease Efficacy Analytical methods Policy and regulatory Economics and healthcare delivery New technologies and innovations Safety and toxicology Miscellaneous All submitted material with scientific content will undergo peer review by the Editor-in-chief and other designees before acceptance for publication.

【译文】《膳食补充剂杂志》(JDS) 发表与膳食补充剂相关的原始研究，根据 1994 年美国膳食补充剂健康和教育法案 (DSHEA) 的定义[108 Stat.第4325章DSHEA 将术语“膳食补充剂”定义为旨在补充饮食的产品（除烟草外），其具有或含有一种或多种以下膳食成分：维生素、矿物质、草药或其他植物、氨基酸、供人类通过增加总膳食摄入量来补充饮食的膳食物质，或浓缩物、代谢物、成分、提取物或上述成分的组合。膳食补充剂旨在以片剂、胶囊、软胶囊、粉末或液体的形式摄入，而不是以传统食品的形式摄入（对个别食物或饮食模式的研究将被拒绝）。该杂志出版以下类型的手稿： 原创研究文章 观点 范围、系统和总体评论 叙述性评论 权威科学团体或政府机构的报告 指南和共识声明 给编辑的信 引用最近《膳食补充剂杂志》原创研究文章的给编辑的信必须在该文章在线发表后 12 周内收到。所有信件在接受之前都将经过编辑审查和决定。 《膳食补充剂杂志》不接受与最近发表的特定原创研究文章无关的信件；包含大量未发表的数据；或进行个人诽谤或谩骂。 《膳食补充剂杂志》不会根据社论、观点、评论等观点发表给编辑的信件，因为这些显然是作者的观点。信件应通过电子邮件提交至 taylor.wallace@me.com 信件必须以 Word 文档形式提供。它们必须是双倍行距，包括行号，应包括标题页，参考文献不应超过 10 条，字数不应超过 1000 字。所有给编辑的信件必须包含利益冲突声明。以下期刊部分适用： 营养、健康和疾病 功效 分析方法 政策和监管 经济和医疗保健提供 新技术和创新 安全和毒理学 其他 所有提交的具有科学内容的材料在接受出版之前将经过主编和其他指定人员的同行评审。